Trial Profile
Bladder base/trigone injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinics.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Sep 2011
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 01 Sep 2011 Results published in the Neurourology and Urodynamics.
- 05 Nov 2010 New trial record.